ANXA1 and in situ carcinoma: IHC confirmed the reduced expression of ANXA1 in the nucleus and cytoplasm of larynx tumors compared to normal tissue, while an increase in ANXA1 expression was detected in the membrane of tumorous versus normal tissue [57].